These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1458005)

  • 1. The chronicle of growth hormone receptor deficiency (Laron syndrome).
    Rosenbloom AL
    Acta Paediatr Suppl; 1992 Sep; 383():117-20. PubMed ID: 1458005
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic use of insulin-like growth factor I: lessons from in vivo animal studies.
    Gluckman PD; Ambler GR
    Acta Paediatr Suppl; 1992 Sep; 383():134-6. PubMed ID: 1458009
    [No Abstract]   [Full Text] [Related]  

  • 3. An update on Laron syndrome.
    Laron Z
    Arch Dis Child; 1993 Mar; 68(3):345-6. PubMed ID: 8466235
    [No Abstract]   [Full Text] [Related]  

  • 4. Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient.
    Laron Z
    J Clin Endocrinol Metab; 1995 May; 80(5):1526-31. PubMed ID: 7744997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human insulin-like growth factor I and treatment in diabetes].
    Koivisto VA
    Duodecim; 1994; 110(23-24):2197-201. PubMed ID: 8654239
    [No Abstract]   [Full Text] [Related]  

  • 6. Disorders of growth hormone resistance in childhood.
    Laron Z
    Curr Opin Pediatr; 1993 Aug; 5(4):474-80. PubMed ID: 8374676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone insensitivity syndrome (Laron syndrome): main characteristics and effects of IGF1 treatment.
    Carel JC; Chaussain JL; Chatelain P; Savage MO
    Diabetes Metab; 1996 Jul; 22(4):251-6. PubMed ID: 8767171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism).
    Walker JL; Ginalska-Malinowska M; Romer TE; Pucilowska JB; Underwood LE
    N Engl J Med; 1991 May; 324(21):1483-8. PubMed ID: 2023608
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and biochemical characteristics of growth hormone receptor deficiency (Laron syndrome).
    Rosenbloom AL; Savage MO; Blum WF; Guevara-Aguirre J; Rosenfeld RG
    Acta Paediatr Suppl; 1992 Sep; 383():121-4. PubMed ID: 1458006
    [No Abstract]   [Full Text] [Related]  

  • 10. Growth hormone-receptor gene in Laron dwarfism.
    Bass S; Wells J
    N Engl J Med; 1990 Mar; 322(12):854-5. PubMed ID: 2308623
    [No Abstract]   [Full Text] [Related]  

  • 11. Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders.
    Savage MO; Attie KM; David A; Metherell LA; Clark AJ; Camacho-Hübner C
    Nat Clin Pract Endocrinol Metab; 2006 Jul; 2(7):395-407. PubMed ID: 16932322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent nonsense mutations in the growth hormone receptor from patients with Laron dwarfism.
    Amselem S; Sobrier ML; Duquesnoy P; Rappaport R; Postel-Vinay MC; Gourmelen M; Dallapiccola B; Goossens M
    J Clin Invest; 1991 Mar; 87(3):1098-102. PubMed ID: 1999489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Growth hormone receptor and dwarfism].
    Postel-Vinay MC
    Rev Prat; 1994 May; 44(10):1281-5. PubMed ID: 7939185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of heterozygosity for the E180 splice mutation causing growth hormone receptor deficiency in Ecuador on IGF-I, IGFBP-3, and stature.
    Guevara-Aguirre J; Rosenbloom AL; Guevara-Aguirre M; Yariz K; Saavedra J; Baumbach L; Shuster J
    Growth Horm IGF Res; 2007 Jun; 17(3):261-4. PubMed ID: 17350302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Laron syndrome by loss of functions of growth hormone receptor].
    Kaji H
    Nihon Rinsho; 2002 Feb; 60(2):306-12. PubMed ID: 11857918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular defects of the growth hormone receptor gene, including a new mutation, in Laron syndrome patients in Israel: relationship between defects and ethnic groups.
    Shevah O; Rubinstein M; Laron Z
    Isr Med Assoc J; 2004 Oct; 6(10):630-3. PubMed ID: 15473594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point mutations in the growth hormone receptor gene of patients with Laron syndrome.
    Amselem S; Duriez B; Sobrier ML; Duquesnoy P; Goossens M
    Acta Paediatr Suppl; 1992 Sep; 383():132-3. PubMed ID: 1458008
    [No Abstract]   [Full Text] [Related]  

  • 18. Laron syndrome due to a post-receptor defect: response to IGF-I treatment.
    Laron Z; Klinger B; Eshet R; Kaneti H; Karasik A; Silbergeld A
    Isr J Med Sci; 1993 Dec; 29(12):757-63. PubMed ID: 8300382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of hormone binding in COS-7 cells expressing a mutated growth hormone receptor found in Laron dwarfism.
    Edery M; Rozakis-Adcock M; Goujon L; Finidori J; Lévi-Meyrueis C; Paly J; Djiane J; Postel-Vinay MC; Kelly PA
    J Clin Invest; 1993 Mar; 91(3):838-44. PubMed ID: 8450064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-I treatment of children with Laron syndrome (primary growth hormone insensitivity).
    Laron Z
    Pediatr Endocrinol Rev; 2008 Mar; 5(3):766-71. PubMed ID: 18367997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.